Liver Injuries and Cancer
Valsartan is an angiotensin II receptor blocker (ARB) used to treat hypertension (high blood pressure), recent heart attacks and heart failure.
The Valsartan lawsuits claim that numerous batches of Valsartan have been found to be contaminated with the cancer-causing substances, including N-nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), and/or N-Methylnitrosobutyric acid (NMBA).
Anvil Legal Group is accepting clients who took valsartan and have been diagnosed with liver, kidney, stomach, or intestinal cancer.
What to know about Valsartan lawsuits
Several drug companies have voluntarily recalled their blood pressure and heart medication that contains valsartan after it was discovered that the medication might have become contaminated in the manufacturing plants it was being produced.
The companies involved include:
- A-S Medication Solutions
- Bryant Rank Prepack
- Camber Pharmaceuticals
- Hetero Labs, Inc.
- HJ Harkins Company
- Major Pharmaceuticals
- Mylan Pharmaceuticals
- Northwind Pharmaceuticals
- NuCare Pharmaceuticals
- Preferred Pharmaceuticals
- Prinston Pharmaceutical
- RemedyRepack Inc.
- Solco Healthcare
- Teva Pharmaceuticals
- Torrent Pharmaceuticals Limited
A complete list of the recalled products can be found here.
Valsartan Side Effects and Injuries
Short-term exposure to N-nitrosodimethylamine (NDMA) can cause liver damage, such as liver fibrosis and scarring. Long-term exposure can increase the risk of liver, kidney, and lung tumors.
NDMA is not currently produced in pure form or commercially used in the United States, except for research purposes. It was formerly used in the production of liquid rocket fuel, antioxidants, additives for lubricants, and softeners for copolymers.
- abdominal cramps
- enlarged liver
- reduced function of the liver
- kidneys and lungs